Reliability of a medication adherence measure in an outpatient setting

Marie Krousel-Wood1, Paul Muntner, Ann Jannu

  • 1Research Division, Ochsner Clinic Foundation, Department of Epidemiology, Tulane University Health Sciences Center, School of Public Health and Tropical Medicine, New Orleans, Louisiana 70121, USA. mawood@ochsner.org

Insights

The Hill-Bone Compliance Scale

Area of Science:

  • Medical adherence research
  • Hypertension management
  • Geriatric medicine

Background:

  • Measuring medication compliance in outpatient settings is challenging.
  • The Hill-Bone Compliance Scale is a potential tool for assessing adherence.
  • Reliable measurement tools are needed for effective hypertension management.

Purpose of the Study:

  • To evaluate the reliability of the Hill-Bone Compliance Scale.
  • To assess medication compliance in elderly hypertensive patients.
  • To determine the scale's utility in outpatient settings.

Main Methods:

  • Cross-sectional survey of 239 community-dwelling hypertensive patients.
  • Self-administered questionnaire including demographic data and the Hill-Bone Compliance Scale.
  • Analysis of the nine-item medication compliance subscale using Cronbach's alpha and correlation.

Main Results:

  • The medication compliance subscale showed a Cronbach's alpha of 0.68.
  • Items within the subscale demonstrated good internal consistency.
  • Older age, white ethnicity, and higher education were associated with higher self-reported compliance.

Conclusions:

  • The medication compliance subscale of the Hill-Bone Compliance Scale is reliable.
  • The scale may be a valuable instrument for identifying noncompliant patients.
  • This tool can aid in improving medication adherence in hypertension care.
Abstract

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...